The ADC PB-vcMMAE-5 was administered intravenously at doses 1, 3, 6 or 9 mg/kg, once per week for five weeks. On day 31 from the first ADC infusion, most alive mice were sacrificed, and tumors were ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback